James conducts medical research within the ECU Melanoma Research Group.
B (Bachelor Degree), Edith Cowan University, 2010 .
B (Bachelor Degree), Edith Cowan University, 2009 .
Recent Research Grants
Predictive significance of circulating tumour cells (CTCs), circulating tumour DNA (ctDNA) and serum vascular endothelial growth factor (VEGF) in advanced melanoma patients treated with pembrolizumab,
Merck Sharp and Dohme (Australia) Pty Ltd,
2015 - 2016, $73,300.
Neon Transfection System and Biomedical Research Grade -30oC Freezer for Alzheimer?s and Melanoma Research,
National Health and Medical Research Council,
Equipment Grant 2011,
Characterisation and Quantification of Circulating Melanoma Cells,
Cancer Council of WA Inc,
Cancer Council, Scholarship,
Recent Publications (within the last five years)
Klinac, D., Gray, E., Freeman, J., Reid, A., Bowyer, S., Millward, M., Ziman, M., (2014), Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma. BMC Cancer, 14(1), Article number 423, United Kingdom, DOI: 10.1186/1471-2407-14-423.
Freeman, J., Gray, E., Milward, M., Pearce, R., Ziman, M., (2012), Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells. Journal of Translational Medicine, 10(1), art. no. 192 , United Kingdom, DOI: 10.1186/1479-5876-10-192.